AAREY DRUGS AND PHARMACEUTICALS LIMITED
L99999MH1990PLC056538
DataDelta records 1 directors, 14 financial line items, 108 NSE events, and 0 group companies for AAREY DRUGS AND PHARMACEUTICALS LIMITED. Appointment dates and ownership percentages are withheld until they pass a data-quality check.
- ISIN
- INE198H01019
- NSE
- AAREYDRUGS
- BSE
- 524412
- Listing
- Listed
- Status
- Active
- State
- maharashtra
- Class
- Public
- Industry
- Community, personal and Social Services
Events
50 shown of 108
| Date | Type | Status | Title |
|---|---|---|---|
| 2026-09-23 | TradingWindow | Announced | Aarey Drugs & Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |
| 2026-09-23 | TradingWindow | Announced | Aarey Drugs & Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |
| 2026-09-11 | ShareholderMeeting | Completed | Aarey Drugs & Pharmaceuticals Limited has informed the Exchange about the AGM Intimation letter that has been sent to the Shareholders under Regulation 36(1)(b) of the SEBI Listing Regulations, 2015 |
| 2026-09-08 | ShareholderMeeting | Completed | Aarey Drugs & Pharmaceuticals Limited has informed the Exchange regarding ''.Aarey Drugs & Pharmaceuticals Limited has informed the Exchange regarding 'Intimation of Book Closure/ E-Voting period for the 36th Annual General Meeting |
| 2026-09-08 | ShareholderMeeting | Completed | Aarey Drugs & Pharmaceuticals Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 30, 2026 |
| 2026-09-05 | BoardMeeting | Completed | Aarey Drugs & Pharmaceuticals Limited has informed the Exchange regarding Outcome of Board Meeting held on September 05, 2026. |
| 2026-08-14 | BoardMeeting | Completed | Aarey Drugs & Pharmaceuticals Limited has submitted to the Exchange, the unaudited financial results for the period ended Jun 30, 2026. |
| 2026-08-07 | BoardMeeting | Completed | Aarey Drugs and Pharmaceuticals limited has informed the Exchange about Board Meeting to be held on 14-Aug-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended June 2026 . |
| 2026-08-07 | FinancialResults | Completed | To consider and approve the financial results for the period ended Jun 30, 2026 |
| 2026-08-06 | BoardMeeting | Completed | Aarey Drugs & Pharmaceuticals Limited has informed the Exchange regarding Outcome of Board Meeting held on August 06, 2026. |
| 2026-07-06 | Acquisition | Announced | Nimit Rajesh Ghatalia has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. |
| 2026-07-01 | Acquisition | Announced | Nimit Rajesh Ghatalia has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. |
| 2026-06-26 | TradingWindow | Announced | Aarey Drugs & Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |
| 2026-05-30 | BoardMeeting | Completed | Aarey Drugs & Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026. |
| 2026-05-29 | BoardMeeting | Completed | Aarey Drugs & Pharmaceuticals Limited has informed the Exchange about Board Meeting to be held on 30-May-2026 to inter-alia consider and approve the Audited Financial results of the Company for the Yearly ended March 2026 . |
| 2026-05-29 | BoardMeeting | Completed | AAREYDRUGS : 30-May-2026 : The Company has informed the Exchange that a Board meeting to be held on May 29, 2026 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on May 30, 2026, To consider and approve the financial results for the period ended March 31, 2026 |
| 2026-05-25 | BoardMeeting | Completed | Aarey Drugs & Pharmaceuticals Limited has informed the Exchange about Board Meeting to be held on 29-May-2026 to inter-alia consider and approve the Audited Financial results of the Company for the Yearly ended March 2026 . |
| 2026-05-25 | FinancialResults | Completed | To consider and approve the financial results for the period ended March 31, 2026 |
| 2026-05-11 | FinancialResults | Completed | The Exchange had sought clarification from Aarey Drugs & Pharmaceuticals Limited for the quarter ended 31-Dec-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: The response of the Company is enclosed. |
| 2026-03-26 | TradingWindow | Announced | Aarey Drugs & Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |
| 2026-03-12 | FinancialResults | Completed | The Exchange has sought clarification from Aarey Drugs & Pharmaceuticals Limited for the quarter ended 31-Dec-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results submitted in XBRL with discrepancies. The response of the Company is awaited. |
| 2026-02-11 | BoardMeeting | Completed | Aarey Drugs & Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025. |
| 2026-02-04 | FinancialResults | Completed | To consider and approve the financial results for the period ended December 31, 2025 |
| 2026-02-04 | BoardMeeting | Completed | Aarey Drugs & Pharmaceuticals Limited has informed the Exchange about Board Meeting to be held on 11-Feb-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended December 2025 . |
| 2025-12-29 | TradingWindow | Announced | Aarey Drugs & Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |
| 2025-11-13 | BoardMeeting | Completed | Aarey Drugs & Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025. |
| 2025-11-08 | FinancialResults | Completed | To consider and approve the financial results for the period ended September 30, 2025 |
| 2025-11-08 | BoardMeeting | Completed | Aarey Drugs & Pharmaceuticals Limited has informed the Exchange about Board Meeting to be held on 13-Nov-2025 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2025 . |
| 2025-10-01 | ShareholderMeeting | Completed | Aarey Drugs & Pharmaceuticals Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 29, 2025 |
| 2025-09-29 | TradingWindow | Announced | Aarey Drugs & Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |
| 2025-09-29 | ShareholderMeeting | Completed | Aarey Drugs & Pharmaceuticals Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 29, 2025 |
| 2025-09-24 | ShareholderMeeting | Completed | Aarey Drugs & Pharmaceuticals Limited has informed the Exchange regarding 'Corrigendum to Integrated Annual Report for the 35th Annual General Meeting for the Financial Year 2024-25'. |
| 2025-09-06 | ShareholderMeeting | Completed | Aarey Drugs & Pharmaceuticals Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 29, 2025 |
| 2025-09-06 | ShareholderMeeting | Completed | Aarey Drugs & Pharmaceuticals Limited has informed the Exchange regarding 'Aarey Drugs & Pharmaceuticals Limited has informed the Exchange regarding 'Intimation of Book Closure/ E-Voting period for the 35th Annual General Meeting'. |
| 2025-09-04 | BoardMeeting | Completed | Aarey Drugs & Pharmaceuticals Limited has informed the Exchange regarding Revised Outcome of Board meeting held on September 03, 2025. |
| 2025-09-03 | ShareholderMeeting | Approved | Aarey Drugs & Pharmaceuticals Limited has informed the Exchange regarding Re-Appointment of Statutory Auditor & Appoinment of Secretarial Auditor of the company w.e.f. September 03, 2025 subject to approval of Shareholders in the ensuing Annual General Meeting |
| 2025-09-03 | BoardMeeting | Completed | Aarey Drugs & Pharmaceuticals Limited has informed the Exchange regarding Board meeting held on September 03, 2025. |
| 2025-08-13 | BoardMeeting | Completed | Aarey Drugs & Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2025. |
| 2025-08-07 | FinancialResults | Completed | To consider and approve the Unaudited financial results for the period ended Jun 30, 2025 |
| 2025-08-07 | BoardMeeting | Completed | Aarey Drugs & Pharmaceuticals Limited has informed the Exchange about Board Meeting to be held on 13-Aug-2025 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended June 2025 . |
| 2025-07-30 | FinancialResults | Completed | Aarey Drugs & Pharmaceuticals Limited has informed the Exchange regarding Revised Filing of Audited Financial Results for the Year Ended 31st March, 2025''. |
| 2025-06-27 | Acquisition | Announced | Aarey Drugs & Pharmaceuticals Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. |
| 2025-06-24 | TradingWindow | Announced | Aarey Drugs & Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |
| 2025-05-30 | BoardMeeting | Completed | Aarey Drugs & Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended March 31, 2025. |
| 2025-05-30 | BoardMeeting | Completed | Aarey Drugs & Pharmaceuticals Limited has informed the Exchange regarding Board meeting held on May 30, 2025. |
| 2025-05-23 | BoardMeeting | Completed | Aarey Drugs & Pharmaceuticals Limited has informed the Exchange regarding Board meeting held on May 23, 2025. |
| 2025-05-22 | FinancialResults | Completed | To consider and approve the financial results for the period ended March 31, 2025 |
| 2025-05-22 | FinancialResults | Completed | To consider and approve the financial results for the period ended March 31, 2025 |
| 2025-05-22 | BoardMeeting | Completed | AAREY DRUGS & PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 30-May-2025 to inter-alia consider and approve the Audited Financial results of the Company for the Yearly ended March 2025 . |
| 2025-04-09 | Disclosure | Announced | Significant movement in price has been observed in Aarey Drugs & Pharmaceuticals Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Aarey Drugs & Pharmaceuticals Limited has submitted their response. |
Directors
1 shown of 1
| Name | DIN | Designation | Status |
|---|---|---|---|
| To Continuation of Directorship of Mr.NimitGhatalia | 07069841 | Director | Active |
Financials
14 shown of 14
| Year | Metric | Value | Unit |
|---|---|---|---|
| 2024-25 | Depreciation | 194.49 | Lakhs |
| 2024-25 | EmployeeBenefits | 80.55 | Lakhs |
| 2024-25 | FinanceCosts | 466.44 | Lakhs |
| 2024-25 | OtherIncome | 981.24 | Lakhs |
| 2024-25 | Revenue | 47,394.33 | Lakhs |
| 2024-25 | TotalExpenses | 47,765.38 | Lakhs |
| 2024-25 | TotalIncome | 48,375.57 | Lakhs |
| 2023-24 | Depreciation | 169.8 | Lakhs |
| 2023-24 | EmployeeBenefits | 71.84 | Lakhs |
| 2023-24 | FinanceCosts | 437.53 | Lakhs |
| 2023-24 | OtherIncome | 696.49 | Lakhs |
| 2023-24 | Revenue | 39,561.79 | Lakhs |
| 2023-24 | TotalExpenses | 39,723.99 | Lakhs |
| 2023-24 | TotalIncome | 40,258.28 | Lakhs |
Group companies
0 shown of 0
| Company | Relationship | Country |
|---|